Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |